Abstract
THE first evidence that human herpesvirus could transform cultured cells was provided by Munyon et al.1 who showed that the thymidine kinase activity of herpes simplex could be expressed in mouse-derived L cells lacking this enzyme (LTK− cells). The oncogenic potential of human herpes virus was demonstrated by Duff and Rapp2,3 who showed that hamster embryo cells transformed by ultraviolet-inactivated herpes simplex virus (HSV) were oncogenic in newborn hamsters. Further evidence of HSV transformation has been described in cultured human, rat and mouse cells4–7. The exact role played by HSV in transformation of primary embryo cells and the amount of information (if any) required to maintain the transformed state is not known. Temperature-sensitive (ts) mutants of HSV-2, HG 52 have been shown to complement each other8. These ts mutants may be used in complementation tests together with rat embryo cells transformed by another ts mutant to demonstrate the expression of herpes information in the transformed line. We report here evidence of such complementation between an HSV-2 ts mutant-transformed rat embryo line and three superinfecting HSV-2 ts mutants. This complementation suggests that this oncogenically transformedline can express herpes information sufficient to complement at least three genes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Munyon, W., Kraiselburd, D., Davis, D., and Mann, J., J. Virol., 7, 813–820 (1971).
Duff, R., and Rapp, F., J. Virol., 8, 469–477 (1971).
Duff, R., and Rapp, F., J. Virol., 12, 209–217 (1973).
Darai, G., and Munk, K., Nature new Biol., 241, 268–269 (1973).
Darai, G., and Munk, K., in Second int. Symp. Oncogenesis Herpesviruses, 1, 437–443 (International Agency for Research on Cancer, Lyon, 1975).
Takahashi, M., and Yamanishi, K., Virology, 61, 306–311 (1974).
Boyd, A., Orme, T., and Boone, C., in Second int. Symp. Oncogenesis Herpesviruses, 1, 429–435 (International Agency for Research on Cancer, Lyon, 1975).
Timbury, M. C., J. gen. Virol., 13, 373–376 (1971).
Macnab, J. C. M., J. gen. Virol., 24, 143–153 (1974).
Macnab, J. C. M., in Second int. Symp. Oncogenesis Herpesviruses, 1, 227–235 (International Agency for Research on Cancer, Lyon, 1975).
Kimura, S., Esparza, J., Beynish-Melnick, M., and Schaffer, P. A., Intervirology, 3, 162–169 (1974).
Jamieson, A. T., Gentry, G. A., and Subak-Sharpe, J. H., J. gen. Virol., 24, 465–480 (1974).
Hay, J., Moss, H., Jamieson, A. T., and Timbury, M. C., J. gen. Virol., 31, 65–73 (1976).
Halliburton, I. W., and Timbury, M. C., Virology, 54, 60–68 (1973).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
MACNAB, J., TIMBURY, M. Complementation of ts mutants by a herpes simplex virus ts-transformed cell line. Nature 261, 233–235 (1976). https://doi.org/10.1038/261233a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/261233a0
This article is cited by
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.